Mood & Mental Health

·

News

Colorado Company Develops Psilocybin Microdose Drug for FDA Approval

Colorado Company Develops Psilocybin Microdose Drug for FDA Approval

Psilocybin mushrooms

What they found

AJNA BioSciences is developing a psilocybin mushroom microdose formulation seeking FDA approval as an antidepressant alternative.

AJNA BioSciences is developing a psilocybin mushroom microdose formulation seeking FDA approval as an antidepressant alternative.

How solid is it?

n/a

n/a

Not a study

Not a study

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Compound

psilocybin

psilocybin

Published in

The Denver Post

The Denver Post

Covered in Shroom Scan

Section

Around the web

Around the web

As it ran in Shroom Scan

AJNA BioSciences, a Colorado-based company, is developing a microdose formulation of psilocybin mushrooms that’s aiming for FDA approval as a natural antidepressant alternative. The company was profiled in The Denver Post is in the final stages of its drug formulation process.

AJNA BioSciences, a Colorado-based company, is developing a microdose formulation of psilocybin mushrooms that’s aiming for FDA approval as a natural antidepressant alternative. The company was profiled in The Denver Post is in the final stages of its drug formulation process.

USDA initiative explores natural fungicides for specialty crops

Read the original study ↗

Get Shroom Scan

Next study

How Yeast, a Fungus, Has Evolved Alongside Humans ›

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.

See what's inside →